FA11s1.i
Merge
PascalFrancis
Racine
Merge
Checkpoint
PascalFrancis
Racine
PascalFrancis
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Merge (PascalFrancis)

Index « FA11s1.i » - entrée « SMOLEN (Josef S.) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
SMOLEN (J.) < SMOLEN (Josef S.) < SNIR (A.)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 8.
Ident.Authors (with country if any)Title
000003 (2005) Josef S. Smolen ; Kurt Redlich ; Jochen Zwerina ; Daniel Aletaha ; Günter Steiner ; Georg SchettPro-inflammatory cytokines in rheumatoid arthritis : Pathogenetic and therapeutic aspects
000012 (2007) Josef S. Smolen ; Daniel Aletaha ; Marcus Koeller ; Michael H. Weisman ; Paul EmeryNew therapies for treatment of rheumatoid arthritis
000015 (2008) Tim Bongartz ; Josef S. Smolen ; Andre Beaulieu ; Andrea Rubbert-Roth ; Cesar Ramos-Remus ; Josef Rovensky ; Emma Alecock ; Thasia Woodworth ; Rieke AltenEffect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study) : a double-blind, placebo-controlled, randomised trial. Commentary
000047 (2010) Patrick Garnero ; Elizabeth Thompson ; Thasia Woodworth ; Josef S. SmolenRapid and Sustained Improvement in Bone and Cartilage Turnover Markers With the Anti-Interleukin-6 Receptor Inhibitor Tocilizumab Plus Methotrexate in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate: Results From a Substudy of the Multicenter Double-Blind, Placebo-Controlled Trial of Tocilizumab in Inadequate Responders to Methotrexate Alone
000103 (2011) Josef S. Smolen ; Daniel AletahaInterleukin-6 Receptor Inhibition With Tocilizumab and Attainment of Disease Remission in Rheumatoid Arthritis: The Role of Acute-Phase Reactants
000174 (2012) Josef S. Smolen ; José C. Martinez Avila ; Daniel AletahaTocilizumab inhibits progression of joint damage in rheumatoid arthritis irrespective of its anti-inflammatory effects: disassociation of the link between inflammation and destruction
000175 (2012) Monika Schoels ; Daniel Aletaha ; Josef S. Smolen ; John B. WongComparative effectiveness and safety of biological treatment options after tumour necrosis factor α inhibitor failure in rheumatoid arthritis: systematic review and indirect pairwise meta-analysis
000218 (2013) Mark C. Genovese ; Andrea Rubbert-Roth ; Josef S. Smolen ; Joel Kremer ; Majed Khraishi ; Juan Gomez-Reino ; Anthony Sebba ; Robert Pilson ; Sarah Williams ; Ronald Van VollenhovenLongterm Safety and Efficacy of Tocilizumab in Patients with Rheumatoid Arthritis: A Cumulative Analysis of Up to 4.6 Years of Exposure

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PascalFrancis/Merge

HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Merge/FA11s1.i -k "SMOLEN (Josef S.)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Merge/FA11s1.i  \
                -Sk "SMOLEN (Josef S.)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PascalFrancis/Merge/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PascalFrancis
   |étape=   Merge
   |type=    indexItem
   |index=    FA11s1.i
   |clé=    SMOLEN (Josef S.)
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021